Yet, relatively little is known about STAT target genes in CTCL and how STAT3, STAT5, and their co-activators and/or co-repressors regulate of expression of disease-associated genes. The gene discussed is STAT5A; the disease is primary cutaneous T-cell non-Hodgkin lymphoma.